Evidence map›Paper›PMID 24788811›Full record

ArticlePloS one2014

Expression of a humanized viral 2A-mediated lux operon efficiently generates autonomous bioluminescence in human cells.

Tingting Xu, Steven Ripp, Gary S Sayler, Dan M Close

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Molecular architecture and diversity of StopGo/2A translational recoding.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Autonomous multicolor bioluminescence imaging in bacteria, mammalian, and plant hosts.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Bioluminescent Imaging Systems for Assay Developments.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Continuous and Real-Time In Vivo Autobioluminescent Imaging in a Mouse Model.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  17. Autonomous bioluminescence imaging of single mammalian cells with the bacterial bioluminescence system.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  18. Molecular Imaging with Reporter Genes: Has Its Promise Been Delivered?Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tingting XuThe Joint Institute for Biological Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America.
Steven Ripp490 BioTech, Inc., Knoxville, Tennessee, United States of America.
Gary S SaylerThe Joint Institute for Biological Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America.
Dan M Close490 BioTech, Inc., Knoxville, Tennessee, United States of America.
490 BioTech (United States) · USOak Ridge National Laboratory · US

Funding

Expressing bacterial bioluminescence in human cell lines: Engineering autobioluminescent reporter cells to screen for endocrine disruptor chemicalsR44ES022567 · NIEHS · 490 BIOTECH, INC. · PI MORRISON, DAN · 2015 to 2016
$996k
Development of Noninvasive Bioluminescence Imaging for Cancer Diagnosis and TheraR21CA127745 · NCI · UNIVERSITY OF TENNESSEE KNOXVILLE · PI SAYLER, GARY S · 2007 to 2008
$239k
Expressing bacterial bioluminescence in human cell lines: Engineering autobiolumiR43ES022567 · NIEHS · 490 BIOTECH, INC. · PI MORRISON, DAN · 2013 to 2013
$138k
NCI NIH HHS CA127745-01NCI NIH HHS R21 CA127745NIEHS NIH HHS 1R43ES022567-01NIEHS NIH HHS R43 ES022567NIEHS NIH HHS R44 ES022567
6 · The paper itself

Abstract

backgroundExpression of autonomous bioluminescence from human cells was previously reported to be impossible, suggesting that all bioluminescent-based mammalian reporter systems must therefore require application of a potentially influential chemical substrate. While this was disproven when the bacterial luciferase (lux) cassette was demonstrated to function in a human cell, its expression required multiple genetic constructs, was functional in only a single cell type, and generated a significantly reduced signal compared to substrate-requiring systems. Here we investigate the use of a humanized, viral 2A-linked lux genetic architecture for the efficient introduction of an autobioluminescent phenotype across a variety of human cell lines. METHODOLOGY/PRINCIPAL

findingsThe lux cassette was codon optimized and assembled into a synthetic human expression operon using viral 2A elements as linker regions. Human kidney, breast cancer, and colorectal cancer cell lines were both transiently and stably transfected with the humanized operon and the resulting autobioluminescent phenotype was evaluated using common imaging instrumentation. Autobioluminescent cells were screened for cytotoxic effects resulting from lux expression and their utility as bioreporters was evaluated through the demonstration of repeated monitoring of single populations over a prolonged period using both a modified E-SCREEN assay for estrogen detection and a classical cytotoxic compound detection assay for the antibiotic Zeocin. Furthermore, the use of self-directed bioluminescent initiation in response to target detection was assessed to determine its amenability towards deployment as fully autonomous sensors. In all cases, bioluminescent measurements were supported with traditional genetic and transcriptomic evaluations. CONCLUSIONS/SIGNIFICANCE: Our results demonstrate that the viral 2A-linked, humanized lux genetic architecture successfully produced autobioluminescent phenotypes in all cell lines tested without the induction of cytotoxicity. This autobioluminescent phenotype allowed for repeated interrogation of populations and self-directed control of bioluminescent activation with detection limits and EC50 values similar to traditional reporter systems, making the autobioluminescent cells amenable to automated monitoring and significantly reducing the time and cost required to perform bioluminescent workflows.

Indexed as

Gene Expression Regulation, EnzymologicOperonBacterial ProteinsCell Line, TumorCell SurvivalCytomegalovirusHCT116 CellsHEK293 CellsHumansLuciferasesLuminescent MeasurementsPromoter Regions, GeneticRecombinant Fusion ProteinsReproducibility of ResultsTransfectionBacterial ProteinsLuciferasesRecombinant Fusion Proteins

Identifiers

PMID24788811
PMCPMC4008522
OpenAlexW2114214386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.